On the recommendation of the Pharmacotherapy Board of Directors (BOD), ACCP President Curtis Haas has appointed ACCP members Jerry Bauman, Pharm.D., FCCP, and Susan Fagan, Pharm.D., FCCP, BCPS, to serve 2-year terms on the Pharmacotherapy BOD, effective January 1, 2014. They will replace outgoing directors Julie Johnson, Pharm.D., FCCP, BCPS, and Glen Schumock, Pharm.D., MBA, FCCP, BCPS, who will complete their respective terms at the end of 2013.

Dr. Bauman is currently interim vice president for health affairs at the University of Illinois and dean at the University of Illinois at Chicago (UIC) College of Pharmacy. He holds academic appointments as a professor in the Departments of Pharmacy Practice and Medicine, Section of Cardiology, at UIC. His area of research and scholarship is the clinical pharmacology of cocaine and the drugs used to treat cardiac rhythm disorders, specifically their ability to paradoxically provoke life-threatening arrhythmias. He is a past president of ACCP and currently serves as a scientific editor for Pharmacotherapy.

Dr. Fagan is the Albert W. Jowdy Professor of Pharmacy Care at the University of Georgia (UGA) and an adjunct professor of neurology at the Medical College of Georgia (MCG) in Augusta, Georgia. She also serves as assistant dean and founding director of the Center for Pharmacy and Experimental Therapeutics at MCG. She is recognized nationally and internationally for her research in stroke, currently funded by both the NIH and VA Merit Review. She has served previously on the ACCP Board of Regents and the ACCP Research Institute Board of Trustees. In April 2013, she was named Distinguished Research Professor at UGA.

Drs. Bauman and Fagan will join the three continuing members of the Pharmacotherapy BOD, William Miller, Pharm.D., FCCP (BOD Chairman); Michael Maddux, Pharm.D., FCCP; and Edith Nutescu, Pharm.D., FCCP.